Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Amphastar Pharma
(NQ:
AMPH
)
41.11
+0.28 (+0.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Amphastar Pharma
< Previous
1
2
Next >
Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
April 01, 2024
Via
ACCESSWIRE
Amphastar Pharmaceuticals to Present at the Barclays 26th Annual Global Healthcare Conference
March 06, 2024
Via
ACCESSWIRE
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023
February 28, 2024
Via
ACCESSWIRE
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2024
February 20, 2024
Via
ACCESSWIRE
Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 02, 2024
Via
ACCESSWIRE
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2023
November 08, 2023
Via
ACCESSWIRE
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2023
August 08, 2023
Via
ACCESSWIRE
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2023
May 09, 2023
Via
ACCESSWIRE
Lilly to Divest BAQSIMI to Amphastar
April 24, 2023
Via
ACCESSWIRE
Amphastar Pharmaceuticals to Present at the Piper Sandler 35th Annual Healthcare Conference
November 20, 2023
Via
ACCESSWIRE
Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference
November 09, 2023
Via
ACCESSWIRE
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023
November 01, 2023
Via
ACCESSWIRE
Amphastar Pharmaceuticals Announces Pricing of Offering of $300.0 Million of Convertible Senior Notes
September 13, 2023
Via
ACCESSWIRE
Amphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes
September 11, 2023
Via
ACCESSWIRE
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2022
November 07, 2022
Via
ACCESSWIRE
Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference
August 31, 2023
Via
ACCESSWIRE
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023
August 02, 2023
Via
ACCESSWIRE
Amphastar Pharmaceuticals Completes Acquisition of BAQSIMI from Lilly
June 30, 2023
Via
ACCESSWIRE
Promising Small Biotech Amphastar Sees Actionable Pullback
June 28, 2023
Small-cap Amphastar Pharmaceuticals is pulling back from recent highs in an orderly fashion, potentially offering a new entry point after beating Q1 views.
Via
MarketBeat
Amphastar Pharmaceuticals Inc. (NASDAQ: AMPH) Records 52-Week High Tuesday Morning
June 20, 2023
Via
Investor Brand Network
Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference
May 31, 2023
Via
ACCESSWIRE
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2023
May 03, 2023
Via
ACCESSWIRE
Amphastar Pharmaceuticals Business Update and Hold Conference Call on April 24th, 2023
April 24, 2023
Via
ACCESSWIRE
Amphastar Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 12, 2023
Via
ACCESSWIRE
Amphastar Pharmaceuticals Receives FDA Approval for Naloxone Hydrochloride Nasal Spray 4mg
March 08, 2023
Via
ACCESSWIRE
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 28, 2023
February 22, 2023
Via
ACCESSWIRE
Amphastar Pharmaceuticals to Present at the Piper Sandler 34th Annual Healthcare Conference
November 22, 2022
Via
ACCESSWIRE
Amphastar Pharmaceuticals to Present at the 2022 Jefferies London Healthcare Conference
November 10, 2022
Via
ACCESSWIRE
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 7, 2022
October 28, 2022
Via
ACCESSWIRE
Amphastar Pharmaceuticals to Present at the Wells Fargo 2022 Healthcare Conference
September 02, 2022
Via
ACCESSWIRE
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.